34 results
Keyword Datscan Remove keyword
-
List item
Human medicine European public assessment report (EPAR): DaTSCAN
ioflupane (123l), Tomography, Emission-Computed, Single-Photon; Lewy Body Disease; Parkinson Disease; Alzheimer Disease
Date of authorisation: 27/07/2000, Revision: 23, Authorised, Last updated: 10/02/2022DaTSCAN Diagnosis Diagnostic Techniques … assessment report (EPAR) for DaTSCAN. It explains how the Committee … the conditions of use for DaTSCAN. What is DaTSCAN? DaTSCAN is a solution for injection … -
List item
Human medicine European public assessment report (EPAR): Striascan
ioflupane (123l), Radionuclide Imaging; Dementia; Movement Disorders
Date of authorisation: 25/06/2019,
, Revision: 2, Authorised, Last updated: 05/12/2022
authorised in the EU called DaTSCAN. How is Striascan used? Striascan … with the reference medicine, DaTSCAN, and do not need to be repeated … shown to be comparable to DaTSCAN. Therefore, the Agency’s … -
List item
Human medicine European public assessment report (EPAR): Celsunax
ioflupane (123i), Radionuclide Imaging; Dementia; Movement Disorders
Date of authorisation: 17/06/2021,, Authorised, Last updated: 02/07/2021
authorised in the EU called DaTSCAN. For more information on A … with the reference medicine, DaTSCAN, and do not need to be repeated … shown to be comparable to DaTSCAN. Therefore, the Agency’s … -
List item
Press release: European Medicines Agency: Committee for Medicinal Products for Human Use 26-28 June 2006
CHMP, Last updated: 29/06/2006DatSCAN … the European Union: DatSCAN ([123I] ioflupane), from … from Alzheimer’s disease. DatSCAN, a diagnostic agent, was … -
List item
News: Public statement on the current shortage of radiopharmaceuticals in the European Union
Last updated: 01/10/2008Zevalin (labelled with 90 Y) 2 DaTSCAN (containing 123 I), Quadramet … -
List item
National expert: Carlo Colosimo, European Medicines Agency (updated)
- Declaration of interests - 41.96 KB | PDF
- Curriculum Vitae - 72.78 KB | PDF
-
List item
Opinions and letters of support on the qualification of novel methodologies for medicine development (updated)
Last updated: 11/05/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 17-20 May 2021
European Medicines Agency, Amsterdam, the Netherlands, from 17/05/2021 to 20/05/2021, Last updated: 07/12/2021 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 07/06/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 31 August-3 September 2020
Virtual meeting, from 31/08/2020 to 03/09/2020, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 February 2013
European Medicines Agency, London, UK, from 04/02/2013 to 07/02/2013, Last updated: 02/06/2012 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 06/06/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 23-26 November 2020
Virtual meeting, from 23/11/2020 to 26/11/2020, Last updated: 27/11/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 March 2018
European Medicines Agency, London, UK, from 05/03/2018 to 08/03/2018, Last updated: 05/03/2018 -
List item
Newsletters (updated)
Last updated: 30/05/2023 -
List item
Download medicine data
Last updated: 02/12/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 March 2023
European Medicines Agency, Amsterdam, the Netherlands, from 13/03/2023 to 16/03/2023, Last updated: 18/08/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13 - 16 March 2023
PRAC, Last updated: 17/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 17-20 May 2010
European Medicines Agency, London, UK, from 17/05/2010 to 20/05/2010, Last updated: 16/02/2010 -
List item
Press release: Committee for Proprietary Medicinal Products (CPMP) 63rd plenary meeting
Last updated: 25/09/2000Decision 27/07/00 Brand name Datscan INN ioflupane Marketing … -
List item
PRAC: Committee agendas, minutes and meeting highlights report archive 2012-2013
Last updated: 01/01/2015 -
List item
Committee for Medicinal Products for Human Use (CHMP): 28-31 May 2018
European Medicines Agency, London, UK, from 28/05/2018 to 31/05/2018, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 25-29 January 2021
Virtual meeting, from 25/01/2021 to 29/01/2021, Last updated: 04/03/2021 -
List item
Annual reports and work programmes (updated)
Last updated: 15/05/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 April 2021
European Medicines Agency, Amsterdam, the Netherlands, from 19/04/2021 to 22/04/2021, Last updated: 07/12/2021